DTaP and Tdap Vaccines Market - Global Outlook and Forecast 2022-2028
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF’s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
This report contains market size and forecasts of DTaP and Tdap Vaccines in global, including the following market information:
Global DTaP and Tdap Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global DTaP and Tdap Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five DTaP and Tdap Vaccines companies in 2021 (%)
The global DTaP and Tdap Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DTaP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DTaP and Tdap Vaccines include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc, Pfizer Inc and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DTaP and Tdap Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DTaP and Tdap Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global DTaP and Tdap Vaccines Market Segment Percentages, by Type, 2021 (%)
Global DTaP and Tdap Vaccines Market Segment Percentages, by Application, 2021 (%)
Global DTaP and Tdap Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies DTaP and Tdap Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies DTaP and Tdap Vaccines revenues share in global market, 2021 (%)
Key companies DTaP and Tdap Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies DTaP and Tdap Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
This report contains market size and forecasts of DTaP and Tdap Vaccines in global, including the following market information:
Global DTaP and Tdap Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global DTaP and Tdap Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five DTaP and Tdap Vaccines companies in 2021 (%)
The global DTaP and Tdap Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DTaP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DTaP and Tdap Vaccines include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc, Pfizer Inc and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DTaP and Tdap Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DTaP and Tdap Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global DTaP and Tdap Vaccines Market Segment Percentages, by Type, 2021 (%)
- DTaP
- Td
- Tdap
Global DTaP and Tdap Vaccines Market Segment Percentages, by Application, 2021 (%)
- Adult
- Pediatric
Global DTaP and Tdap Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies DTaP and Tdap Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies DTaP and Tdap Vaccines revenues share in global market, 2021 (%)
Key companies DTaP and Tdap Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies DTaP and Tdap Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi Pasteur
- GlaxoSmithKline
- Protein Sciences Corporation
- Novartis AG
- Seqirus
- Merck Sharp & Dohme Corp
- Astellas Pharma US, Inc
- Pfizer Inc
- Johnson & Johnson
- Lanzhou Institute of Biological Products Co., Ltd
- AstraZeneca
- Emergent BioSolutions Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 DTaP and Tdap Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DTaP and Tdap Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DTAP AND TDAP VACCINES OVERALL MARKET SIZE
2.1 Global DTaP and Tdap Vaccines Market Size: 2021 VS 2028
2.2 Global DTaP and Tdap Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global DTaP and Tdap Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top DTaP and Tdap Vaccines Players in Global Market
3.2 Top Global DTaP and Tdap Vaccines Companies Ranked by Revenue
3.3 Global DTaP and Tdap Vaccines Revenue by Companies
3.4 Global DTaP and Tdap Vaccines Sales by Companies
3.5 Global DTaP and Tdap Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 DTaP and Tdap Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers DTaP and Tdap Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 DTaP and Tdap Vaccines Players in Global Market
3.8.1 List of Global Tier 1 DTaP and Tdap Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 DTaP and Tdap Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global DTaP and Tdap Vaccines Market Size Markets, 2021 & 2028
4.1.2 DTaP
4.1.3 Td
4.1.4 Tdap
4.2 By Type - Global DTaP and Tdap Vaccines Revenue & Forecasts
4.2.1 By Type - Global DTaP and Tdap Vaccines Revenue, 2017-2022
4.2.2 By Type - Global DTaP and Tdap Vaccines Revenue, 2023-2028
4.2.3 By Type - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global DTaP and Tdap Vaccines Sales & Forecasts
4.3.1 By Type - Global DTaP and Tdap Vaccines Sales, 2017-2022
4.3.2 By Type - Global DTaP and Tdap Vaccines Sales, 2023-2028
4.3.3 By Type - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global DTaP and Tdap Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global DTaP and Tdap Vaccines Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global DTaP and Tdap Vaccines Revenue & Forecasts
5.2.1 By Application - Global DTaP and Tdap Vaccines Revenue, 2017-2022
5.2.2 By Application - Global DTaP and Tdap Vaccines Revenue, 2023-2028
5.2.3 By Application - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global DTaP and Tdap Vaccines Sales & Forecasts
5.3.1 By Application - Global DTaP and Tdap Vaccines Sales, 2017-2022
5.3.2 By Application - Global DTaP and Tdap Vaccines Sales, 2023-2028
5.3.3 By Application - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global DTaP and Tdap Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global DTaP and Tdap Vaccines Market Size, 2021 & 2028
6.2 By Region - Global DTaP and Tdap Vaccines Revenue & Forecasts
6.2.1 By Region - Global DTaP and Tdap Vaccines Revenue, 2017-2022
6.2.2 By Region - Global DTaP and Tdap Vaccines Revenue, 2023-2028
6.2.3 By Region - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global DTaP and Tdap Vaccines Sales & Forecasts
6.3.1 By Region - Global DTaP and Tdap Vaccines Sales, 2017-2022
6.3.2 By Region - Global DTaP and Tdap Vaccines Sales, 2023-2028
6.3.3 By Region - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America DTaP and Tdap Vaccines Revenue, 2017-2028
6.4.2 By Country - North America DTaP and Tdap Vaccines Sales, 2017-2028
6.4.3 US DTaP and Tdap Vaccines Market Size, 2017-2028
6.4.4 Canada DTaP and Tdap Vaccines Market Size, 2017-2028
6.4.5 Mexico DTaP and Tdap Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe DTaP and Tdap Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe DTaP and Tdap Vaccines Sales, 2017-2028
6.5.3 Germany DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.4 France DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.5 U.K. DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.6 Italy DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.7 Russia DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.9 Benelux DTaP and Tdap Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia DTaP and Tdap Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia DTaP and Tdap Vaccines Sales, 2017-2028
6.6.3 China DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.4 Japan DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.5 South Korea DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.7 India DTaP and Tdap Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America DTaP and Tdap Vaccines Revenue, 2017-2028
6.7.2 By Country - South America DTaP and Tdap Vaccines Sales, 2017-2028
6.7.3 Brazil DTaP and Tdap Vaccines Market Size, 2017-2028
6.7.4 Argentina DTaP and Tdap Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, 2017-2028
6.8.3 Turkey DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.4 Israel DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.6 UAE DTaP and Tdap Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporate Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Major Product Offerings
7.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Pasteur Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Major Product Offerings
7.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporate Summary
7.3.2 Protein Sciences Corporation Business Overview
7.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Major Product Offerings
7.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Protein Sciences Corporation Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG DTaP and Tdap Vaccines Major Product Offerings
7.4.4 Novartis AG DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Seqirus
7.5.1 Seqirus Corporate Summary
7.5.2 Seqirus Business Overview
7.5.3 Seqirus DTaP and Tdap Vaccines Major Product Offerings
7.5.4 Seqirus DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Seqirus Key News
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporate Summary
7.6.2 Merck Sharp & Dohme Corp Business Overview
7.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Major Product Offerings
7.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Merck Sharp & Dohme Corp Key News
7.7 Astellas Pharma US, Inc
7.7.1 Astellas Pharma US, Inc Corporate Summary
7.7.2 Astellas Pharma US, Inc Business Overview
7.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Major Product Offerings
7.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma US, Inc Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc DTaP and Tdap Vaccines Major Product Offerings
7.8.4 Pfizer Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Inc Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson DTaP and Tdap Vaccines Major Product Offerings
7.9.4 Johnson & Johnson DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Major Product Offerings
7.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca DTaP and Tdap Vaccines Business Overview
7.11.3 AstraZeneca DTaP and Tdap Vaccines Major Product Offerings
7.11.4 AstraZeneca DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporate Summary
7.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Business Overview
7.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Major Product Offerings
7.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Emergent BioSolutions Inc Key News
8 GLOBAL DTAP AND TDAP VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global DTaP and Tdap Vaccines Production Capacity, 2017-2028
8.2 DTaP and Tdap Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global DTaP and Tdap Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DTAP AND TDAP VACCINES SUPPLY CHAIN ANALYSIS
10.1 DTaP and Tdap Vaccines Industry Value Chain
10.2 DTaP and Tdap Vaccines Upstream Market
10.3 DTaP and Tdap Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DTaP and Tdap Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 DTaP and Tdap Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DTaP and Tdap Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DTAP AND TDAP VACCINES OVERALL MARKET SIZE
2.1 Global DTaP and Tdap Vaccines Market Size: 2021 VS 2028
2.2 Global DTaP and Tdap Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global DTaP and Tdap Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top DTaP and Tdap Vaccines Players in Global Market
3.2 Top Global DTaP and Tdap Vaccines Companies Ranked by Revenue
3.3 Global DTaP and Tdap Vaccines Revenue by Companies
3.4 Global DTaP and Tdap Vaccines Sales by Companies
3.5 Global DTaP and Tdap Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 DTaP and Tdap Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers DTaP and Tdap Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 DTaP and Tdap Vaccines Players in Global Market
3.8.1 List of Global Tier 1 DTaP and Tdap Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 DTaP and Tdap Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global DTaP and Tdap Vaccines Market Size Markets, 2021 & 2028
4.1.2 DTaP
4.1.3 Td
4.1.4 Tdap
4.2 By Type - Global DTaP and Tdap Vaccines Revenue & Forecasts
4.2.1 By Type - Global DTaP and Tdap Vaccines Revenue, 2017-2022
4.2.2 By Type - Global DTaP and Tdap Vaccines Revenue, 2023-2028
4.2.3 By Type - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global DTaP and Tdap Vaccines Sales & Forecasts
4.3.1 By Type - Global DTaP and Tdap Vaccines Sales, 2017-2022
4.3.2 By Type - Global DTaP and Tdap Vaccines Sales, 2023-2028
4.3.3 By Type - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global DTaP and Tdap Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global DTaP and Tdap Vaccines Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application - Global DTaP and Tdap Vaccines Revenue & Forecasts
5.2.1 By Application - Global DTaP and Tdap Vaccines Revenue, 2017-2022
5.2.2 By Application - Global DTaP and Tdap Vaccines Revenue, 2023-2028
5.2.3 By Application - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global DTaP and Tdap Vaccines Sales & Forecasts
5.3.1 By Application - Global DTaP and Tdap Vaccines Sales, 2017-2022
5.3.2 By Application - Global DTaP and Tdap Vaccines Sales, 2023-2028
5.3.3 By Application - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global DTaP and Tdap Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global DTaP and Tdap Vaccines Market Size, 2021 & 2028
6.2 By Region - Global DTaP and Tdap Vaccines Revenue & Forecasts
6.2.1 By Region - Global DTaP and Tdap Vaccines Revenue, 2017-2022
6.2.2 By Region - Global DTaP and Tdap Vaccines Revenue, 2023-2028
6.2.3 By Region - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global DTaP and Tdap Vaccines Sales & Forecasts
6.3.1 By Region - Global DTaP and Tdap Vaccines Sales, 2017-2022
6.3.2 By Region - Global DTaP and Tdap Vaccines Sales, 2023-2028
6.3.3 By Region - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America DTaP and Tdap Vaccines Revenue, 2017-2028
6.4.2 By Country - North America DTaP and Tdap Vaccines Sales, 2017-2028
6.4.3 US DTaP and Tdap Vaccines Market Size, 2017-2028
6.4.4 Canada DTaP and Tdap Vaccines Market Size, 2017-2028
6.4.5 Mexico DTaP and Tdap Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe DTaP and Tdap Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe DTaP and Tdap Vaccines Sales, 2017-2028
6.5.3 Germany DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.4 France DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.5 U.K. DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.6 Italy DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.7 Russia DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries DTaP and Tdap Vaccines Market Size, 2017-2028
6.5.9 Benelux DTaP and Tdap Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia DTaP and Tdap Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia DTaP and Tdap Vaccines Sales, 2017-2028
6.6.3 China DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.4 Japan DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.5 South Korea DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia DTaP and Tdap Vaccines Market Size, 2017-2028
6.6.7 India DTaP and Tdap Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America DTaP and Tdap Vaccines Revenue, 2017-2028
6.7.2 By Country - South America DTaP and Tdap Vaccines Sales, 2017-2028
6.7.3 Brazil DTaP and Tdap Vaccines Market Size, 2017-2028
6.7.4 Argentina DTaP and Tdap Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, 2017-2028
6.8.3 Turkey DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.4 Israel DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia DTaP and Tdap Vaccines Market Size, 2017-2028
6.8.6 UAE DTaP and Tdap Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Corporate Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Major Product Offerings
7.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Pasteur Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Major Product Offerings
7.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Corporate Summary
7.3.2 Protein Sciences Corporation Business Overview
7.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Major Product Offerings
7.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Protein Sciences Corporation Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG DTaP and Tdap Vaccines Major Product Offerings
7.4.4 Novartis AG DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Seqirus
7.5.1 Seqirus Corporate Summary
7.5.2 Seqirus Business Overview
7.5.3 Seqirus DTaP and Tdap Vaccines Major Product Offerings
7.5.4 Seqirus DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Seqirus Key News
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Corporate Summary
7.6.2 Merck Sharp & Dohme Corp Business Overview
7.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Major Product Offerings
7.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Merck Sharp & Dohme Corp Key News
7.7 Astellas Pharma US, Inc
7.7.1 Astellas Pharma US, Inc Corporate Summary
7.7.2 Astellas Pharma US, Inc Business Overview
7.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Major Product Offerings
7.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharma US, Inc Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc DTaP and Tdap Vaccines Major Product Offerings
7.8.4 Pfizer Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Inc Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson DTaP and Tdap Vaccines Major Product Offerings
7.9.4 Johnson & Johnson DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
7.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
7.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Major Product Offerings
7.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Lanzhou Institute of Biological Products Co., Ltd Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca DTaP and Tdap Vaccines Business Overview
7.11.3 AstraZeneca DTaP and Tdap Vaccines Major Product Offerings
7.11.4 AstraZeneca DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Emergent BioSolutions Inc
7.12.1 Emergent BioSolutions Inc Corporate Summary
7.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Business Overview
7.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Major Product Offerings
7.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Emergent BioSolutions Inc Key News
8 GLOBAL DTAP AND TDAP VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global DTaP and Tdap Vaccines Production Capacity, 2017-2028
8.2 DTaP and Tdap Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global DTaP and Tdap Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DTAP AND TDAP VACCINES SUPPLY CHAIN ANALYSIS
10.1 DTaP and Tdap Vaccines Industry Value Chain
10.2 DTaP and Tdap Vaccines Upstream Market
10.3 DTaP and Tdap Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DTaP and Tdap Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of DTaP and Tdap Vaccines in Global Market
Table 2. Top DTaP and Tdap Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global DTaP and Tdap Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global DTaP and Tdap Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global DTaP and Tdap Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global DTaP and Tdap Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers DTaP and Tdap Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers DTaP and Tdap Vaccines Product Type
Table 9. List of Global Tier 1 DTaP and Tdap Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DTaP and Tdap Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 46. Sanofi Pasteur Corporate Summary
Table 47. Sanofi Pasteur DTaP and Tdap Vaccines Product Offerings
Table 48. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline DTaP and Tdap Vaccines Product Offerings
Table 51. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Protein Sciences Corporation Corporate Summary
Table 53. Protein Sciences Corporation DTaP and Tdap Vaccines Product Offerings
Table 54. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG DTaP and Tdap Vaccines Product Offerings
Table 57. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Seqirus Corporate Summary
Table 59. Seqirus DTaP and Tdap Vaccines Product Offerings
Table 60. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Merck Sharp & Dohme Corp Corporate Summary
Table 62. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Offerings
Table 63. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Astellas Pharma US, Inc Corporate Summary
Table 65. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Offerings
Table 66. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Inc Corporate Summary
Table 68. Pfizer Inc DTaP and Tdap Vaccines Product Offerings
Table 69. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Johnson & Johnson Corporate Summary
Table 71. Johnson & Johnson DTaP and Tdap Vaccines Product Offerings
Table 72. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
Table 74. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Offerings
Table 75. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca DTaP and Tdap Vaccines Product Offerings
Table 78. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Emergent BioSolutions Inc Corporate Summary
Table 80. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Offerings
Table 81. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. DTaP and Tdap Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global DTaP and Tdap Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global DTaP and Tdap Vaccines Production by Region, 2017-2022 (K Units)
Table 85. Global DTaP and Tdap Vaccines Production by Region, 2023-2028 (K Units)
Table 86. DTaP and Tdap Vaccines Market Opportunities & Trends in Global Market
Table 87. DTaP and Tdap Vaccines Market Drivers in Global Market
Table 88. DTaP and Tdap Vaccines Market Restraints in Global Market
Table 89. DTaP and Tdap Vaccines Raw Materials
Table 90. DTaP and Tdap Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical DTaP and Tdap Vaccines Downstream
Table 92. DTaP and Tdap Vaccines Downstream Clients in Global Market
Table 93. DTaP and Tdap Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of DTaP and Tdap Vaccines in Global Market
Table 2. Top DTaP and Tdap Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global DTaP and Tdap Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global DTaP and Tdap Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global DTaP and Tdap Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global DTaP and Tdap Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers DTaP and Tdap Vaccines Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers DTaP and Tdap Vaccines Product Type
Table 9. List of Global Tier 1 DTaP and Tdap Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DTaP and Tdap Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global DTaP and Tdap Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global DTaP and Tdap Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global DTaP and Tdap Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global DTaP and Tdap Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales, (K Units), 2023-2028
Table 46. Sanofi Pasteur Corporate Summary
Table 47. Sanofi Pasteur DTaP and Tdap Vaccines Product Offerings
Table 48. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline DTaP and Tdap Vaccines Product Offerings
Table 51. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Protein Sciences Corporation Corporate Summary
Table 53. Protein Sciences Corporation DTaP and Tdap Vaccines Product Offerings
Table 54. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG DTaP and Tdap Vaccines Product Offerings
Table 57. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Seqirus Corporate Summary
Table 59. Seqirus DTaP and Tdap Vaccines Product Offerings
Table 60. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Merck Sharp & Dohme Corp Corporate Summary
Table 62. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Offerings
Table 63. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Astellas Pharma US, Inc Corporate Summary
Table 65. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Offerings
Table 66. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Inc Corporate Summary
Table 68. Pfizer Inc DTaP and Tdap Vaccines Product Offerings
Table 69. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Johnson & Johnson Corporate Summary
Table 71. Johnson & Johnson DTaP and Tdap Vaccines Product Offerings
Table 72. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Lanzhou Institute of Biological Products Co., Ltd Corporate Summary
Table 74. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Offerings
Table 75. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca DTaP and Tdap Vaccines Product Offerings
Table 78. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Emergent BioSolutions Inc Corporate Summary
Table 80. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Offerings
Table 81. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. DTaP and Tdap Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global DTaP and Tdap Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global DTaP and Tdap Vaccines Production by Region, 2017-2022 (K Units)
Table 85. Global DTaP and Tdap Vaccines Production by Region, 2023-2028 (K Units)
Table 86. DTaP and Tdap Vaccines Market Opportunities & Trends in Global Market
Table 87. DTaP and Tdap Vaccines Market Drivers in Global Market
Table 88. DTaP and Tdap Vaccines Market Restraints in Global Market
Table 89. DTaP and Tdap Vaccines Raw Materials
Table 90. DTaP and Tdap Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical DTaP and Tdap Vaccines Downstream
Table 92. DTaP and Tdap Vaccines Downstream Clients in Global Market
Table 93. DTaP and Tdap Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. DTaP and Tdap Vaccines Segment by Type
Figure 2. DTaP and Tdap Vaccines Segment by Application
Figure 3. Global DTaP and Tdap Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global DTaP and Tdap Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global DTaP and Tdap Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. DTaP and Tdap Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DTaP and Tdap Vaccines Revenue in 2021
Figure 9. By Type - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global DTaP and Tdap Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global DTaP and Tdap Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 19. US DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 24. Germany DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 33. China DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global DTaP and Tdap Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production DTaP and Tdap Vaccines by Region, 2020 VS 2027
Figure 50. DTaP and Tdap Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. DTaP and Tdap Vaccines Segment by Type
Figure 2. DTaP and Tdap Vaccines Segment by Application
Figure 3. Global DTaP and Tdap Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global DTaP and Tdap Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global DTaP and Tdap Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. DTaP and Tdap Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DTaP and Tdap Vaccines Revenue in 2021
Figure 9. By Type - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global DTaP and Tdap Vaccines Price (USD/Unit), 2017-2028
Figure 12. By Application - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global DTaP and Tdap Vaccines Price (USD/Unit), 2017-2028
Figure 15. By Region - Global DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 19. US DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 24. Germany DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 33. China DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa DTaP and Tdap Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE DTaP and Tdap Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global DTaP and Tdap Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production DTaP and Tdap Vaccines by Region, 2020 VS 2027
Figure 50. DTaP and Tdap Vaccines Industry Value Chain
Figure 51. Marketing Channels
